If you've had a total shoulder replacement, you might not realize your surgeon was likely aiming for a very specific angle when placing the new socket. Getting that angle just right is a major technical focus, based on the belief that it's crucial for a good result. A new analysis pooled data from 15 studies, looking at over 1,100 shoulder replacements. It compared patients whose final socket angle was less than 15 degrees with those whose angle was 15 degrees or more. The key finding? There were no clinically significant differences between the groups in how patients reported their pain and function, their range of motion, or their complication rates. This review suggests that, at least in the short to medium term, surgeons may not need to stress as much about hitting a perfect target angle. The data we have so far doesn't show it makes a noticeable difference to how people feel and move. However, the authors are clear that this is a look at the evidence we have now. A big caveat is that we don't yet know if a more angled implant might lead to problems like loosening or wear many years down the line. More studies with longer follow-up are needed to answer that.
Meta-analysis finds no clinically significant outcome differences with postoperative glenoid retroversion ≥15° after aTSADoes shoulder implant angle matter for recovery? A new review suggests maybe not
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This systematic review and meta-analysis examined the association between postoperative glenoid component retroversion and clinical outcomes following primary anatomic total shoulder arthroplasty (aTSA). The analysis pooled data from 15 studies encompassing 1,190 shoulders, comparing outcomes between patients with postoperative glenoid retroversion <15° and those with retroversion ≥15°. The primary outcome was patient-reported clinical outcomes, with secondary outcomes including range of motion and complications.
The main finding was that no clinically significant differences were noted in patient-reported outcome scores, range of motion, or complications between the two retroversion groups. The analysis did not report specific effect sizes, absolute numbers, or statistical confidence intervals for these comparisons. The study setting and follow-up duration were not reported in the available data.
Safety and tolerability data, including adverse events and discontinuations, were not reported. A key limitation acknowledged by the authors is the need for future studies with long-term follow-up to assess the durability of these findings over time. The review's practice relevance is restrained, indicating it did not find evidence that postoperative glenoid component retroversion of <15° or ≥15° was associated with clinically significant differences in patient outcomes in the studied timeframe.